2022
DOI: 10.1080/15376516.2022.2124898
|View full text |Cite
|
Sign up to set email alerts
|

Sulfur mustard analog 2-chloroethyl ethyl sulfide increases triglycerides by activating DGAT1-dependent biogenesis and inhibiting PGC1ɑ-dependent fat catabolism in immortalized human bronchial epithelial cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 36 publications
0
1
0
Order By: Relevance
“…A-922500 (Abbott Laboratories, 2009) was tested in diet-induced rat models of hypertriglyceridemia at 3 mg/kg, reducing circulating TAGs and free fatty acids. This compound was also used to block lipid droplet formation in response to mustard gas in cell cultured human bronchial epithelial cells (Ye et al, 2023). GSK3008356, developed by GlaxoSmithKline and featuring an unrelated chemical structure, is a selective DGAT1 inhibitor developed to address non-alcoholic steatohepatitis (NASH).…”
Section: Pf-04620110 Was Developed By Pfizer Global Research and Deve...mentioning
confidence: 99%
“…A-922500 (Abbott Laboratories, 2009) was tested in diet-induced rat models of hypertriglyceridemia at 3 mg/kg, reducing circulating TAGs and free fatty acids. This compound was also used to block lipid droplet formation in response to mustard gas in cell cultured human bronchial epithelial cells (Ye et al, 2023). GSK3008356, developed by GlaxoSmithKline and featuring an unrelated chemical structure, is a selective DGAT1 inhibitor developed to address non-alcoholic steatohepatitis (NASH).…”
Section: Pf-04620110 Was Developed By Pfizer Global Research and Deve...mentioning
confidence: 99%